This topic contains a solution. Click here to go to the answer

Author Question: The dynamic phase of the VMH syndrome is associated with A) hypophagia. B) weight gain. C) ... (Read 76 times)

Marty

  • Hero Member
  • *****
  • Posts: 553
The dynamic phase of the VMH syndrome is associated with
 
  A) hypophagia.
  B) weight gain.
  C) lipogenesis.
  D) all of the above
  E) both B and C

Question 2

The VMH hyperphagia syndrome comprises two phases. In chronological sequence, these phases are the
 
  A) aphagia phase and the adipsia phase.
  B) adipsia phase and the aphagia phase.
  C) dynamic phase and the static phase.
  D) hyperphagia phase and the hypophagia phase.
  E) static phase and the dynamic phase.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

beccamahon

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

Answer: E

Answer to Question 2

Answer: C




Marty

  • Member
  • Posts: 553
Reply 2 on: Jun 22, 2018
Excellent


ryansturges

  • Member
  • Posts: 338
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Certain rare plants containing cyanide include apricot pits and a type of potato called cassava. Fortunately, only chronic or massive ingestion of any of these plants can lead to serious poisoning.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library